Site Selection for Life Sciences Companies | KPMG | CH
close
Share with your friends

Site Selection for Life Sciences Companies in Europe 2018

Site Selection for Life Sciences Companies

KPMG's 2018 report looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe.

1000

Key contact

Head of International Headquarters

KPMG Switzerland

Contact

Related content

Site Selection for Life Sciences Companies in Europe

For Life Sciences companies looking to expand into Europe, there is a lot to think about. What is the best route to market, most effective launch sequence, and top location for a company’s specific specialization?

In the 2018 edition of KPMG’s Site Selection for Life Sciences Companies in Europe, we identify five key work streams involved in building a successful operating model. Our popular site selection analysis compares the attractiveness of different European countries, focusing on the most relevant factors such as innovation, infrastructure, taxation and incentives.

 

Watch our webcast or download the report below:

© 2018 KPMG Holding AG is a member of the KPMG network of independent firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss legal entity. All rights reserved.

KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.

Connect with us

 

Request for proposal

 

Submit